Evidence map›Paper›PMID 31182925›Full record

ArticleInternational journal of biological sciences2019

Construing the Biochemical and Molecular Mechanism Underlying the

Yixuan Wang, Li Bian, Tania Chakraborty, Torsha Ghosh, Pallakhi Chanda, Souvik Roy

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Advances in Anti-Cancer Activities of Flavonoids inInternational journal of molecular sciences · 2022
    Review
  7. Review
  8. Article
  9. Therapeutic approaches to colorectal cancerFrontiers in microbiology · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yixuan WangDepartment of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, 130033, China.
Li BianDepartment of Radiotherapy, The Second Hospital of Jilin university, Changchun, Jilin, 130041, China.
Tania ChakrabortyDepartment of Pharmaceutical Technology, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata -700053, West Bengal, India.
Torsha GhoshDepartment of Pharmaceutical Technology, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata -700053, West Bengal, India.
Pallakhi ChandaDepartment of Pharmaceutical Technology, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata -700053, West Bengal, India.
Souvik RoyDepartment of Pharmaceutical Technology, NSHM Knowledge Campus- Kolkata, 124 B.L. Saha Road, Kolkata -700053, West Bengal, India.
Jilin University · CNSecond Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In pursuit of a novel approach in colon cancer therapy, we explored the ability of ruthenium baicalein complex to eradicate colon cancer by efficiently targeting various apoptotic pathways on human colon cancer cell line and on a DMH and DSS induced murine model of colorectal cancer. In this study, we provide direct proof of the chemotherapeutic potential of the ruthenium baicalein complex by activating p-53 dependent intrinsic apoptosis and modulating the AKT/mTOR and WNT/β- catenin pathways. The ruthenium baicalein complex was synthesized and its characterizations were accomplished through various spectroscopic techniques followed by assessment of antioxidant potential by DPPH, FRAP, and ABTS methods.

Indexed as

AnimalsAntineoplastic AgentsApoptosisbeta CateninBiphenyl CompoundsCatalaseCell ProliferationColonic NeoplasmsColorectal NeoplasmsFlavanonesGlutathioneHT29 CellsHumansMalePicratesProto-Oncogene Proteins c-akt1,1-diphenyl-2-picrylhydrazylAntineoplastic Agentsbaicaleinbeta CateninBiphenyl CompoundsCatalaseFlavanonesGlutathionePicratesProto-Oncogene Proteins c-aktRutheniumSuperoxide DismutaseTOR Serine-Threonine Kinasescolon carcinogenesisin vitro studyruthenium baicalein complexstructural characterizationtoxicity study

Identifiers

PMID31182925
PMCPMC6535785
OpenAlexW2946911492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.